• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

18.63 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 18.63
Bid (Size) 14.88 (90)
Ask (Size) 18.77 (3)
Prev. Close 18.63
Today's Range 18.63 - 18.63
52wk Range 14.57 - 25.11
Shares Outstanding 29,926,846
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM
July 17, 2025
From Fulgent Genetics, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
July 15, 2025
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+1.1%
+1.1%
1 Month
-3.6%
-3.6%
3 Month
+0.9%
+0.9%
6 Month
+5.7%
+5.7%
1 Year
-16.6%
-16.6%

More News

Read More
Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025
July 10, 2025
From Fulgent Genetics, Inc.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
July 06, 2025
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
July 01, 2025
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm
June 30, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
June 30, 2025
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
June 28, 2025
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
June 26, 2025
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
June 25, 2025
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
June 24, 2025
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
June 23, 2025
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
June 20, 2025
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
June 18, 2025
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
June 15, 2025
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
June 10, 2025
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm
June 09, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
June 06, 2025
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm
June 02, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
June 02, 2025
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
May 28, 2025
From Pomerantz LLP
Via GlobeNewswire
FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm
May 24, 2025
From Schall Law Firm
Via Business Wire
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
May 22, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT
May 22, 2025
From Pomerantz LLP
Via GlobeNewswire
Fulgent Reports First Quarter 2025 Financial Results
May 02, 2025
From Fulgent Genetics, Inc.
Via Business Wire

Frequently Asked Questions

Is Fulgent Genetics, Inc. - Common Stock publicly traded?
Yes, Fulgent Genetics, Inc. - Common Stock is publicly traded.
What exchange does Fulgent Genetics, Inc. - Common Stock trade on?
Fulgent Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fulgent Genetics, Inc. - Common Stock?
The ticker symbol for Fulgent Genetics, Inc. - Common Stock is FLGT on the Nasdaq Stock Market
What is the current price of Fulgent Genetics, Inc. - Common Stock?
The current price of Fulgent Genetics, Inc. - Common Stock is 18.63
When was Fulgent Genetics, Inc. - Common Stock last traded?
The last trade of Fulgent Genetics, Inc. - Common Stock was at 07/22/25 04:00 PM ET
What is the market capitalization of Fulgent Genetics, Inc. - Common Stock?
The market capitalization of Fulgent Genetics, Inc. - Common Stock is 557.54M
How many shares of Fulgent Genetics, Inc. - Common Stock are outstanding?
Fulgent Genetics, Inc. - Common Stock has 558M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap